Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2019

May 13, 2019

284_dirs_2019-05-13_1c74284c-cc85-4ddc-a7d9-973f62ea0346.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-05-10

Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-10 Common Stock M 1509.0000 $0.0000 Acquired 3316.8290 Direct
2019-05-10 Common Stock F 517.0000 $78.3300 Disposed 2799.8290 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-10 Restricted Stock Unit $ M 1509.0000 Disposed 2019-05-10 Common Stock (1509.0000) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.